Market revenue in 2023 | USD 20.9 million |
Market revenue in 2030 | USD 24.6 million |
Growth rate | 2.4% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.84% in 2023. Horizon Databook has segmented the Egypt regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Pharmaceutical products require approval of the Egyptian Drug Authority before they are marketed or distributed in the country. The regulatory process involved is time consuming and prove to be challenging for new entrants.
Central Administration for Pharmaceutical Affairs (CAPA) regulates the medical device industry in the country. In 2018, CAPA expanded its medical device oversight regulations to include all Class I sterile, Class IIa, Class IIb, and Class III medical devices under its oversight.
These regulatory changes are anticipated to drastically change the medical device registration process in the country, thereby facilitating market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Egypt regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Egypt regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account